Literature DB >> 22702255

Remote magnetic navigation in atrial fibrillation.

Tamas Szili-Torok1, Ferdi Akca.   

Abstract

Atrial fibrillation (AF) is of profound public health importance and is largely a disease of aging and is responsible for increased morbidity- and mortality-related healthcare expenditures. Catheter ablation to isolate the pulmonary veins has become the therapy of choice for treatment of drug-refractory AF. Procedures can be very challenging and multiple difficulties must be overcome in order to achieve a successful outcome. The magnetic navigation system (MNS) has advantages in catheter maneuverability, stability and reproducibility. Due to the catheter design safety and efficacy of AF, ablation has increased. New developments are being made to allow fully remote ablation procedures in combination with the MNS. However, new technologies are still necessary to improve MNS ablation for AF.

Entities:  

Mesh:

Year:  2012        PMID: 22702255     DOI: 10.1586/erd.12.11

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  4 in total

1.  Comparisons of efficacy, safety, and recurrence risk factors of paroxysmal and persistent atrial fibrillation catheter ablation using robotic magnetic navigation system.

Authors:  Xiao-Xi Zhao; Ku-Lin Li; Ru-Xing Wang; Jie Zheng; Xiao-Yu Liu; Shi-Peng Dang; Zhi-Ming Yu; Chang-Ying Zhang; Xiang-Jun Yang
Journal:  Clin Cardiol       Date:  2019-03-15       Impact factor: 2.882

Review 2.  Application of magnetic nanoparticles in cell therapy.

Authors:  Yuling Chen; Shike Hou
Journal:  Stem Cell Res Ther       Date:  2022-04-01       Impact factor: 6.832

3.  Dipole charge density mapping integrated in remote magnetic navigation: First-in-human feasibility study.

Authors:  Rita B Gagyi; Anna M E Noten; Sip Wijchers; Sing-Chien Yap; Rohit E Bhagwandien; Mark G Hoogendijk; Tamas Szili-Torok
Journal:  Int J Cardiol Heart Vasc       Date:  2022-07-21

4.  Feasibility of remote magnetic navigation for epicardial ablation.

Authors:  P Abraham; L D Abkenari; E C H Peters; T Szili-Torok
Journal:  Neth Heart J       Date:  2013-09       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.